In focus · trending topic

Cannevert Therapeutics

12 stories · following the connections

Veritas Pharma Establishes New Subsidiary in Puerto Rico, USA

By Nasdaq OMXMay 7, 2018, 7:10 AM UTC

Dr. Michael K. Pugsley Joins Veritas Pharma’s Advisory Board

By Nasdaq OMXApr 18, 2018, 7:50 AM UTC

Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics

By Nasdaq OMXMar 21, 2018, 7:15 AM UTC

Veritas Pharma Signs Letter of Intent with 3 Carbon Extractions Inc.

By Nasdaq OMXMar 8, 2018, 8:10 AM UTC

Veritas Pharma Signs Memorandum of Understanding with BioCan Technologies

By Nasdaq OMXFeb 28, 2018, 8:05 AM UTC

Veritas Pharma Provides Corporate Update on Q1 2018

By Nasdaq OMXFeb 21, 2018, 8:10 AM UTC

Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1

By Nasdaq OMXFeb 20, 2018, 8:10 AM UTC

Veritas’ Research Arm Cannevert Signs Clinical Research Agreement for Human Studies to Assess its Lead Cannabis Strain for Pain

By Nasdaq OMXJan 10, 2018, 10:01 PM UTC